Elritercept

Overview

Elritercept (KER-050) is an investigational bone marrow stimulating medication being studied for use in myelodysplastic syndrome (MDS).

SparkCures ID 664
Generic Name Elritercept
Additional Names KER-050
Treatment Classifications
  • Activin Receptor IIA Inhibitor

Clinical Trials

Resources